Cincinnati Children's Vector Production Facility

Cincinnati, OH

National Center

AAV Lentiviral

1 confirmed programs · 1 sponsors · Last scored 2026-03-15

63.0

Signal Score

○ FDA Inspections ✓ Clinical Trials (1) ○ SEC Filings ○ Press

Quick Facts: Cincinnati Children's Vector Production Facility

Signal Score: 63.0/100 (as of 2026-03-15)
Quality Compliance: Assessment pending
Headquarters: Cincinnati, OH
Modalities: AAV, Lentiviral
Active CGT Programs: 1 confirmed from ClinicalTrials.gov across 1 sponsors
Data Sources: FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By: CDMO Signal — independent CGT manufacturing intelligence platform

Quality Compliance —

No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.

FDA InspectionsNo US records on file

No FDA inspection records found for this manufacturer

Quality score requires FDA inspection data

Operations —

No ClinicalTrials.gov facility matches confirmed for this manufacturer.

Programs 1

Sponsors1

ModalitiesAAV, Lentiviral

1 active programs across 1 sponsors

Modalities: Lentiviral, AAV

1 programs in advanced phases (Phase 2/3)

Source: ClinicalTrials.gov facility matching

NCT00537394 Optimizing Treatment for Treatment-Experienced, HIV-Infected People PHASE3 Completed

Source: ClinicalTrials.gov · Retrieved Mar 20, 2026

Financial Stability

Subsidiary of Cincinnati Children's Hospital

SEC FilingsParent: Cincinnati Children's Hospital

Parent company: Cincinnati Children's Hospital

Financial assessment: 68.0/100

Capacity

1 CGT manufacturing site

1 CGT manufacturing site: Cincinnati, OH

Modalities: AAV, Lentiviral

Capacity assessment: 58.0/100

Source: ClinicalTrials.gov · Retrieved Mar 20, 2026

Represent this organization? Contact us to verify or update this profile.

See all CDMOs in:

AAV CDMOs → Lentiviral CDMOs →